Clinical trial
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma
NCT00172367 · National Taiwan University Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00172367 |
|---|---|
| Title | Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Transitional Cell |
| Intervention type | Drug |
| Interventions | Lycopene |
| Enrollment | 80 |
| Start date | Jan 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 26, 2008 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: